Wolfgang Mück
- No pharmacodynamic (PD) and pharmacokinetic (PK) interaction of riociguat (BAY 63-2521) and aspirinBy Reiner Frey, Wolfgang Mück, Sigrun Unger, Michael Reber, Jörn Krätzschmar, Corina Becker and Georg WensingReiner Frey1Clinical and Pharmacology, Bayer HealthCare AG, Wuppertal, GermanyWolfgang Mück1Clinical and Pharmacology, Bayer HealthCare AG, Wuppertal, GermanySigrun Unger2Global Biostatistics, Bayer HealthCare AG, Wuppertal, GermanyMichael Reber1Clinical and Pharmacology, Bayer HealthCare AG, Wuppertal, GermanyJörn Krätzschmar1Clinical and Pharmacology, Bayer HealthCare AG, Wuppertal, GermanyCorina Becker1Clinical and Pharmacology, Bayer HealthCare AG, Wuppertal, GermanyGeorg Wensing1Clinical and Pharmacology, Bayer HealthCare AG, Wuppertal, Germany
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.